Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BeyondMD vs Gatlan

BeyondMD
Graded #189

Higher grade

vs+8.700000000000003
Gatlan
Graded #389

Lower grade

The verdict

BeyondMD takes it — 66.5/100 to 57.8/100.

BeyondMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBeyondMD +30
75
45
Dose & formulationBeyondMD +24
64
40
Clinical oversightGatlan +8
74
82
Labs & monitoringGatlan +9
53
62
FulfillmentGatlan +5
65
70
Contract termsEven
55
55
BeyondMD · left barGatlan · right bar

The numbers

MetricBeyondMDGatlan
WeighScore66.5/10057.8/100
GradeCC
Scorecard rank#189#389
Semaglutide$139/mo (starting dose, compounded)Not disclosed
Tirzepatide$209/mo (starting dose, compounded)Not disclosed
CoverageCoverage not published44 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
BeyondMD

Graded #189 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Gatlan

Graded #389 · C

Strengths

  • Named Chief Medical Advisor with verifiable credentials — Dr. Robert Lufkin, UCLA/USC professor — rare in this market
  • 44 states explicitly listed — you can confirm coverage without starting the sign-up flow
  • 'Doctor-Level Care, Minus the Friction' positioning targets buyers wanting premium clinical attention
  • Fully online process with concierge delivery and monitoring
  • Compounded tirzepatide confirmed

Where it loses points

  • Pricing not shown publicly — fully gated behind the sign-up flow
  • Unclear whether compounded semaglutide is offered — only tirzepatide is mentioned on the site
  • LegitScript certification status not disclosed
  • 503A/503B pharmacy partner not named, and designation not specified
  • No compounded-medication disclaimer published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard